The global smart patch market is growing at a CAGR of 21.4% during 2025-2030. The increasing occurrence of chronic and lifestyle-associated diseases, rising healthcare expenditure, increasing healthcare spending, and expanding inclination towards personal fitness are the major factors leading to the high demand for smart patches in the global market.
Key players in the smart patch market are catering to the demand of these devices by investing in technologically advanced products in their product portfolio across the globe. In October 2019, Abbott Laboratories partnered with Omada Health, to integrate Abbott’s FreeStyle Libre system with Omada Health’s digital care program. In addition, in July 2019, BioTelemetry, Inc., acquired ADEA Medical AB, to increase its geographic exposure and product offerings to physicians and patients in Europe.
The clinical segment is expected to grow at a faster rate in the global smart patch market during 2025–2030
Based on application, the global smart patch market is subdivided into clinical and non-clinical. Of all applications, the clinical segment is expected to grow at a faster rate in the market during the forecast period, due to escalating acceptance of smart patches to track and observe health. Heart rate is a commonly measured parameter using the smart patch. It also provides time-based recordings of a history of information for improved performance analysis.
Segment / Key Players |
Categorization |
Type |
Transdermal Transmission, Electronic Stimulation, Monitoring |
Technology |
Connected, Regular |
Application |
Clinical, Non-Clinical |
Key Players |
BioTelemetry, Inc., MC10, Inc., Insulet Corporation, Abbott Laboratories, Isansys Lifecare Ltd., iRhythm Technologies, DexCom, Inc., Kenzen, Medtronic plc, and Gentag |
Geography Insight
Geographically, North America is the largest smart patch market in 2020 as in the region the occurrence of chronic and lifestyle-associated diseases is escalating. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2015 approximately 23.1 million people in the U.S. had diabetes.
Geographically, the smart patch market is divided into North America, Europe, Asia-Pacific (APAC), and the Rest of the World (RoW).
Competitive Insight
Some of the key players operating in the global smart patch market are BioTelemetry, Inc., MC10, Inc., Insulet Corporation, Abbott Laboratories, Isansys Lifecare Ltd., iRhythm Technologies, DexCom, Inc., Kenzen, Medtronic plc, AliveCor, Inc., and Gentag.
Key Takeaway from the Report:
Among all the technologies, a regular segment is expected to grow at a substantial rate in the market during the forecast period (2025–2030).
The Report Offers:
Benefits of Report Purchase from VynZ:
Detailed Research
We provide accurate data and in-depth analysis with all-inclusive coverage.
Robust Research Methodology
Robust research methodology and data triangulation to ensure high-quality reports.
Analyst Support
24*7 analyst support – Pre and post-purchase of the report as well as during the project tenure.
Sales Support
24*7 sales support – Hassle-free delivery of the report and quick response and support by the sales team.
Free Customization
20% post-purchase free customization to meet your requirements.
Customer Satisfaction
We claim full customer satisfaction as our core values lie in building long-term relationships.
Security
High level of data security and confidentiality of your information.
The report provides the market value for the base year 2023 and a yearly forecast till 2030 for revenue (USD Billion). The report segments the global smart patch market based on type, application, technology, and region.
Global Smart Patch Market Coverage
Type Insight and Forecast 2025-2030
Application Insight and Forecast 2025-2030
Technology Insight and Forecast 2025-2030
Geographical Segmentation
Smart Patch Market by Region
North America
Europe
Asia-Pacific (APAC)
Rest of the World (RoW)